541
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Falsely elevated serum salicylate concentration secondary to hyperlipidemia

, &
Pages 69-70 | Received 16 Aug 2018, Accepted 21 Aug 2018, Published online: 06 Sep 2018

References

  • Biary R, Kremer A, Goldfarb DS, et al. Falsely elevated salicylate concentration in a patient with hypertriglyceridemia. Toxicol Commun. 2018;2(1):1–2. DOI:10.1080/24734306.2017.1412566.
  • You K, Bittikofer JA. Quantification of salicylate in serum by use of salicylate hydroxylase. Clin Chem. 1984;30(9):1549.
  • Baer DM, Paulson RA. The effect of hyperlipidemia on therapeutic drug assays. Ther Drug Monit. 1987;9(1):72–77.
  • Kroll MH. Evaluating interference caused by lipemia. Clin Chem. 2004;50(11):1968–1969. DOI:10.1373/clinchem.2004.038075.
  • Meany D, Schowinsky J, Clarke W. Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. Clin Biochem. 2008;41(18):1486–1488. doi: 10.1016/j.clinbiochem.2008.09.111.
  • Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem. 1994;40(11 Pt 1):1996–2005.
  • Charlton NP, Lawrence DT, Wallace KL. Falsely elevated salicylate levels. J Med Toxicol. 2008;4(4):310–311. PubMed PMID: 19031386; PubMed Central PMCID: PMCPMC3550119.